STAT3 and leukemia: Recently, Wang’s group reported a potent and effective STAT3 degrader SD-36, which selectively induced rapid STAT3 degradation at low nanomolar concentrations in leukemia and lymphoma cells, and achieved nanomolar cytostatic activity.